Press Release

Cannabis Press Releases

GW Pharmaceuticals receives Australian Therapeutic Goods Administration (TGA) approval for EPIDYOLEXÂŽ (cannabidiol) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy

GW Pharmaceuticals receives Australian Therapeutic Goods Administration (TGA) approval for EPIDYOLEXÂŽ (cannabidiol) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy

LONDON, Sept. 23, 2020 -- GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”, “the Company” or “the Group”), a world leader in discovering, developing and delivering r... Read More...